Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    -1.40 (-3.20%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £66.18m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Issue of Equity

30 Nov 2017 16:31

RNS Number : 0439Y
Maven Income and Growth VCT 3 PLC
30 November 2017
 

Maven Income and Growth VCT 3 PLC

 

Issue of Equity - Dividend Investment Scheme

 

 

The Board of Maven Income and Growth VCT 3 PLC (the Company) confirms that, on 30 November 2017 and under its Dividend Investment Scheme (DIS), the Company issued and allotted 153,836 new ordinary shares of 10p each (Ordinary Shares) at a price of 72.20p per share which, under the Terms and Conditions of the DIS, is equivalent to the latest announced net asset value per share.

 

As a result, and in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, the Company confirms that its issued share capital as at 30 November 2017 comprises 47,016,945 Ordinary Shares, with each share carrying one voting right. The above figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required, under the Disclosure Guidance and Transparency Rules, to notify their interest, or a change to their interest, in the Company.

 

Application has been made to the UK Listing Authority and the London Stock Exchange for the new Ordinary Shares issued under the DIS to be admitted to the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that admission will become effective and dealings will commence on, or around, 6 December 2017.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

30 November 2017

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFFRLDLIVID
Date   Source Headline
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding
27th Mar 20251:06 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:53 pmRNSUnaudited Net Asset Value
18th Mar 20253:37 pmRNSAnnual Financial Report
28th Feb 20254:32 pmRNSTransaction in Own Shares
27th Feb 20251:54 pmRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:17 amRNSDirector/PDMR Shareholding
19th Feb 202510:14 amRNSDirector/PDMR Shareholding
19th Feb 202510:06 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
13th Dec 20242:42 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
25th Oct 20243:49 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 202410:25 amRNSDirector/PDMR Shareholding
6th Sep 202410:01 amRNSIssue of Equity
5th Sep 20242:26 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:40 pmRNSUnaudited Net Asset Value
18th Jul 20245:27 pmRNSHalf-year Report
10th Jul 20245:08 pmRNSTransaction in Own Shares
8th Jul 20244:07 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
10th May 20244:11 pmRNSTransaction in Own Shares
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares
19th Oct 20234:15 pmRNSNet Asset Value

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.